L1CAM and carcinoma: Due to its expression being specific to the Mullerian tract-derived cancers like ovarian and endometrial cancer, L1CAM has been suggested as a possible marker differentiating those carcinomas from cases of metastatic cancer of unknown primary site in women [45].